當(dāng)前位置：   首頁(yè) > 需求大廳

1、丹參提取工藝規(guī)程：企業(yè)現(xiàn)行正在使用的工藝規(guī)程，（不是藥典標(biāo)準(zhǔn)）如白云山、同仁堂、四川依科等廠家最佳； 2、僅限 乙醇回流+水提方式； 3、若試用后采用，追加rmb：2000+   [更多]

求購(gòu)“USPMonographs:Trometamol ”《USP42-NF37》的藥典標(biāo)準(zhǔn)一份.   [更多]

求購(gòu)“Trometamol”《BP2019》的藥典標(biāo)準(zhǔn)一份.   [更多]

需要PDF可以復(fù)制版，謝謝。   [更多]

求購(gòu)左氧氟沙星EP9.8版 需要是PDF可以復(fù)制版 多謝   [更多]

求一份硫酸羥氯喹片的美國(guó)生產(chǎn)廠商，醫(yī)院和零售價(jià)格，和藥品的適應(yīng)癥   [更多]

重點(diǎn)查一下有沒(méi)有3mg/6mg劑型   [更多]

求購(gòu)“Saccharin Sodium” BP2017 和BP2018的藥典標(biāo)準(zhǔn)各一份   [更多]

標(biāo)題：求購(gòu)藥品信息 詳細(xì)要求： 需求名稱：求購(gòu)藥品信息 具體要求：求購(gòu)全文 要求時(shí)間：近期需要 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過(guò)來(lái)看的，謝謝各位藥智的戰(zhàn)友們，價(jià)格可以商量   [更多]

1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1,   [更多]